Skip to main content
OpenTrials

Clinical trial condition

HER2-positive Breast Cancer

Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

202 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

HER2-positive Breast Cancer trial results

Active, Not Recruiting

MARGetuximab Or Trastuzumab (MARGOT)

NCT04425018

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer

NCT05346224

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • the First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • The first affiliated hospital of Anhui Medical University Hefei, Anhui, China
  • The first affiliated hospital of USTC (Anhui Provincial Hospital) Hefei, Anhui, China
View all 79 locations
View Trial Details

Related conditions